ABSTRACT

Objectives:

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor among all brain tumors. As observed in most tumors, Warburg effect is also seen in GBM. Approaches such as chemotherapy, radiotherapy and surgery are used in the treatment of GBM. Unfortunately, these treatment options are not as effective as expected. For this reason, new searches for GBM treatment are being sought. Modified ketogenic diet (MKD) (low glycemic index diet) is one of these novel approaches. The primary purpose of this diet is to increase fat consumption and reduce carbohydrate intake. In this way, in addition to standard chemotherapy and radiotherapy, it is intended to hinder or cease the development of cancer by affecting the intermediate steps of the Warburg effect.

Materials and Methods:

It was aimed to evaluate the effects of MKD on the general health status of GBM patients who were on this diet voluntarily and were followed in the Clinic of Neurosurgery of İbn-i Sina Hospital, Ankara University. For this, their blood parameters were retrospectively analyzed. Although it is reported to be moderate and regenerative in the literature, it is a question of whether especially liver & kidney functions and blood electrolytes undergo any changes during diet. In this retrospective study, the effect of MKD on routine blood parameters (Hb, Htc, MCH, MCV, PLT, WBC, RBC, Na, K, ALT, AST, GGT, vitamin B12, folate, creatinine, BUN, total cholesterol, HDL and LDL) was investigated in patients with GBM under treatment, who voluntarily followed MKD. Data were analyzed using Microsoft Office Excel. The Wilcoxon paired comparison test was used to compare patient data in 0., 1. and 6. months. Ethics committee approval and institutional permission were obtained for the study. The patients’ written consent could not be taken due to the retrospective design of the study and the anonymity of data.

Results:

A clinically insignificant decrease in sodium levels were detected. Normalization of the initially high GGT values was considered as a favorable outcome. Folic acid elevation in the first month was interpreted positively for the patient. The increase in total cholesterol and LDL in the first month was expected because of the high fat content of the diet.

Conclusion:

Modified ketogenic nutrition did not have a negative effect on liver, kidney functions and blood parameters in patients with GBM.

Keywords: Modified Ketogenic Diet (Low Glycemic Index), Warburg Effect, Glioblastoma Multiforme, Blood Parameters

References

Alexander BM, Cloughesy TF. Adult Glioblastoma. J Clin Oncol. 2017;35:2402-2409.

Hanif F, Muzaffar K, Perveen K, et al. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev. 2017;18:3-9.

Jacqueline C, Brazier L, Faugère D, et al. Can intestinal microbiota be associated with non-intestinal cancers? Sci Rep. 2017;7:12722.

Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029-1033.

Otto AM. Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 2016;4:5.

Warburg O, Wind F, Negelein E. The Metabolism of Tumors in the Body. J Gen Physiol. 1927;8:519-530.

Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41:211-218.

Bayley JP, Devilee P. The Warburg effect in 2012. Curr Opin Oncol. 2012;24:62-67.

Champ CE, Palmer JD, Volek JS, et al. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol. 2014;117:125-131.

Panhans CM, Gresham G, Amaral LJ, et al. Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series. Front Neurosci. 2020;14:390.

Zhou W, Mukherjee P, Kiebish MA, et al. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond). 2007;4:5.

Rieger J, Bähr O, Maurer GD, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol. 2014;44:1843-1852.

Schwartz K, Chang HT, Nikolai M, et al. Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature. Cancer Metab. 2015;3:3.

Oudard S, Boitier E, Miccoli L, et al. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res. 1997;17:1903-1911.

Roslin M, Henriksson R, Bergström P, et al. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol. 2003;61:151-160.

Veech RL, Chance B, Kashiwaya Y, et al. Ketone bodies, potential therapeutic uses. IUBMB Life. 2001;51:241-247.

Seyfried TN, Sanderson TM, El-Abbadi MM, et al. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer. 2003;89:1375-1382.

Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol. 2009;19:12-16.

Woolf EC, Scheck AC. The ketogenic diet for the treatment of malignant glioma. J Lipid Res. 2015;56:5-10.

The Effects of Modified Ketogenic Diet on Blood Parameters of Patients with Glioblastoma: A Retrospective Study

ABSTRACT

References